Assetmark Inc. Purchases 249 Shares of Colgate-Palmolive (NYSE:CL)

Assetmark Inc. increased its position in Colgate-Palmolive (NYSE:CLGet Rating) by 2.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,814 shares of the company’s stock after purchasing an additional 249 shares during the period. Assetmark Inc.’s holdings in Colgate-Palmolive were worth $619,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Pacific Global Investment Management Co. lifted its holdings in shares of Colgate-Palmolive by 5.2% in the 3rd quarter. Pacific Global Investment Management Co. now owns 10,482 shares of the company’s stock worth $736,000 after purchasing an additional 520 shares in the last quarter. Kingfisher Capital LLC lifted its stake in Colgate-Palmolive by 47.9% during the 3rd quarter. Kingfisher Capital LLC now owns 10,848 shares of the company’s stock valued at $762,000 after acquiring an additional 3,512 shares in the last quarter. Atria Investments LLC lifted its stake in Colgate-Palmolive by 1.6% during the 3rd quarter. Atria Investments LLC now owns 56,286 shares of the company’s stock valued at $3,954,000 after acquiring an additional 883 shares in the last quarter. Mattern Wealth Management LLC lifted its stake in Colgate-Palmolive by 1.3% during the 3rd quarter. Mattern Wealth Management LLC now owns 11,644 shares of the company’s stock valued at $818,000 after acquiring an additional 152 shares in the last quarter. Finally, Prestige Wealth Management Group LLC lifted its stake in Colgate-Palmolive by 0.4% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 154,034 shares of the company’s stock valued at $10,821,000 after acquiring an additional 569 shares in the last quarter. 77.63% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 1.5 %

Shares of CL opened at $75.20 on Friday. The business has a 50-day moving average of $77.69 and a 200 day moving average of $76.87. Colgate-Palmolive has a fifty-two week low of $67.84 and a fifty-two week high of $84.75. The firm has a market cap of $62.81 billion, a P/E ratio of 32.70, a price-to-earnings-growth ratio of 6.80 and a beta of 0.51. The company has a debt-to-equity ratio of 7.81, a quick ratio of 0.71 and a current ratio of 1.17.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its quarterly earnings data on Friday, October 28th. The company reported $0.74 earnings per share for the quarter, hitting the consensus estimate of $0.74. The company had revenue of $4.46 billion during the quarter, compared to analyst estimates of $4.47 billion. Colgate-Palmolive had a return on equity of 304.29% and a net margin of 10.87%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter last year, the firm posted $0.81 EPS. As a group, research analysts forecast that Colgate-Palmolive will post 2.97 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 14th. Shareholders of record on Monday, January 23rd will be issued a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Friday, January 20th. Colgate-Palmolive’s payout ratio is presently 81.74%.

Analyst Ratings Changes

Several equities analysts have weighed in on CL shares. Wolfe Research started coverage on Colgate-Palmolive in a research note on Monday, November 21st. They set a “market perform” rating on the stock. UBS Group dropped their price objective on Colgate-Palmolive from $90.00 to $80.00 in a research note on Thursday, October 13th. JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $81.00 to $86.00 and gave the company an “overweight” rating in a research report on Friday, January 13th. Credit Suisse Group decreased their target price on Colgate-Palmolive from $88.00 to $85.00 and set an “outperform” rating for the company in a research report on Tuesday, October 18th. Finally, Wells Fargo & Company raised their target price on Colgate-Palmolive from $75.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 3rd. Eight analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $83.58.

Colgate-Palmolive Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLGet Rating).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.